表紙
市場調查報告書

神經科設備的全球市場:2020年∼2024年

Neurology Devices Market by Product and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 547914
出版日期 內容資訊 英文 171 Pages
訂單完成後即時交付
價格
Back to Top
神經科設備的全球市場:2020年∼2024年 Neurology Devices Market by Product and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年11月12日內容資訊: 英文 171 Pages
簡介

全球神經科設備市場上,神經疾病的盛行率的增加,老年人口的增加,神經學的資金提供的增加等成為成長促進因素,在預測期間內預計將以約12%的年複合成長率擴大。但,神經設備的成本,嚴格法規,產品的回收,神經科醫生的不足等要素,可能妨礙在預測期間內神經科設備產業的成長。

本報告提供全球神經科設備市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析
  • 價值鏈分析

第4章 市場規模

  • 市場定義
  • 市場規模(2019年)
  • 市場規模及預測(2019年∼2024年)
  • 市場預測

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各產品

  • 市場區隔:各產品
  • 各產品比較:市場規模及預測(2019年∼2024年)
  • 神經刺激設備
  • 介入性神經設備
  • 腦神經外科裝飾設備
  • 腦脊髓液管理設備
  • 其他
  • 市場機會:各產品

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 技術的進步和新產品的銷售
  • 穿戴式神經設備的強力滲透
  • 在新興國家的醫療觀光的成長

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Co.
  • Boston Scientific Corp.
  • Johnson & Johnson Services Inc.
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • 日本光電
  • Penumbra Inc.
  • Stryker Corp.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR40120

About this market

Technavio's neurology devices market analysis considers sales from neurostimulation devices, interventional neurology devices, neurosurgery devices, cerebrospinal fluid management devices, and other products. Our study also finds the sales of neurology devices in Asia, Europe, North America, and ROW. In 2019, the neurostimulation devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as implantable, programmable devices placed surgically to deliver electrical stimulation to the intended parts of the brain, the spinal cord will play a significant role in the neurostimulation devices segment to maintain its market position. Also, our global neurology devices market report looks at factors such as increasing prevalence of neurological disorders, growing geriatric population, increasing funding on neurology. However, high cost of neurology devices, stringent regulations, and product recall, and shortage of neurologists may hamper the growth of the neurology devices industry over the forecast period.

Overview

Increasing prevalence of neurological disorders

The prevalence of neurological disorders which include PD, MS, sleep apnea, epilepsy, brain tumors, brain aneurysm, brain stroke, and brain tumors is increasing. These disorders are associated with the central and peripheral nervous systems. Patients experience pain, neurological instability, seizures, paralysis, and muscle weakness under these conditions. Several factors including chromosomal abnormalities or congenital defects in genes cause these neurological conditions. Thus, the increasing prevalence of neurological disorders will lead to the expansion of the global neurology devices market at a CAGR of almost 12% during the forecast period.

Strong prevalence of the wearable neurology devices

The growing awareness and need for home care have encouraged the global population to adopt smart wearable devices such as smartwatches and smart bands for seamless monitoring and recording of patient health data through a wireless interface. Additionally, the recorded health data can be shared with healthcare professionals for better patient outcomes. Wearable neurology devices are used for continuous detection and monitoring of patients with neurological disorders such as seizures and PD. The US FDA has already approved an MHealth wearable device, Embrace2, which uses advanced machine learning technology to detect electrodermal activities in patients. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global neurology devices market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of several major players, the global neurology devices market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurology devices manufacturers, that include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Co., Boston Scientific Corp., Johnson & Johnson Services Inc., Medtronic Plc, MicroPort Scientific Corp., Nihon Kohden Corp., Penumbra Inc., and Stryker Corp.

Also, the neurology devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value Chain Analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Neurostimulation devices - Market size and forecast 2019-2024
  • Interventional neurology devices - Market size and forecast 2019-2024
  • Neurosurgery Devices - Market size and forecast 2019-2024
  • Cerebrospinal fluid management devices - Market size and forecast
  • 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Technological advances and new product launches
  • Strong penetration of wearable neurology devices
  • Growing medical tourism in emerging economies

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Co.
  • Boston Scientific Corp.
  • Johnson & Johnson Services Inc.
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • Nihon Kohden Corp.
  • Penumbra Inc.
  • Stryker Corp.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare equipment market
  • Exhibit 02: Segments of global healthcare equipment market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendors: Key offerings
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Product - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Neurostimulation devices - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Neurostimulation devices - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Interventional neurology devices - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Interventional neurology devices - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Neurosurgery devices - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 25: Neurosurgery devices - Year-over-year growth 2020-2024 (%)
  • Exhibit 26: Cerebrospinal fluid management devices - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 27: Cerebrospinal fluid management devices - Year-over-year growth 2020-2024 (%)
  • Exhibit 28: Others - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: Others - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Market opportunity by product
  • Exhibit 31: Customer landscape
  • Exhibit 32: Market share by geography 2019-2024 (%)
  • Exhibit 33: Geographic comparison
  • Exhibit 34: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 37: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 38: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 39: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 40: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 41: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 42: Key leading countries
  • Exhibit 43: Market opportunity
  • Exhibit 44: Increase in the population aged 65 years and above (%)
  • Exhibit 45: Impact of drivers and challenges
  • Exhibit 46: Vendor landscape
  • Exhibit 47: Landscape disruption
  • Exhibit 48: Vendors covered
  • Exhibit 49: Vendor classification
  • Exhibit 50: Market positioning of vendors
  • Exhibit 51: Abbott Laboratories - Vendor overview
  • Exhibit 52: Abbott Laboratories - Business segments
  • Exhibit 53: Abbott Laboratories - Organizational developments
  • Exhibit 54: Abbott Laboratories - Geographic focus
  • Exhibit 55: Abbott Laboratories - Segment focus
  • Exhibit 56: Abbott Laboratories - Key offerings
  • Exhibit 57: B. Braun Melsungen AG - Vendor overview
  • Exhibit 58: B. Braun Melsungen AG - Business segments
  • Exhibit 59: B. Braun Melsungen AG - Organizational developments
  • Exhibit 60: B. Braun Melsungen AG - Geographic focus
  • Exhibit 61: B. Braun Melsungen AG - Segment focus
  • Exhibit 62: B. Braun Melsungen AG - Key offerings
  • Exhibit 63: Becton, Dickinson and Co. - Vendor overview
  • Exhibit 64: Becton, Dickinson and Co. - Business segments
  • Exhibit 65: Becton, Dickinson and Co. - Organizational developments
  • Exhibit 66: Becton, Dickinson and Co. - Geographic focus
  • Exhibit 67: Becton, Dickinson and Co. - Segment focus
  • Exhibit 68: Becton, Dickinson and Co. - Key offerings
  • Exhibit 69: Boston Scientific Corp. - Vendor overview
  • Exhibit 70: Boston Scientific Corp. - Business segments
  • Exhibit 71: Boston Scientific Corp. - Organizational developments
  • Exhibit 72: Boston Scientific Corp. - Geographic focus
  • Exhibit 73: Boston Scientific Corp. - Segment focus
  • Exhibit 74: Boston Scientific Corp. - Key offerings
  • Exhibit 75: Johnson & Johnson Services Inc. - Vendor overview
  • Exhibit 76: Johnson & Johnson Services Inc. - Business segments
  • Exhibit 77: Johnson & Johnson Services Inc. - Organizational developments
  • Exhibit 78: Johnson & Johnson Services Inc. - Geographic focus
  • Exhibit 79: Johnson & Johnson Services Inc. - Segment focus
  • Exhibit 80: Johnson & Johnson Services Inc. - Key offerings
  • Exhibit 81: Medtronic Plc - Vendor overview
  • Exhibit 82: Medtronic Plc - Business segments
  • Exhibit 83: Medtronic Plc - Organizational developments
  • Exhibit 84: Medtronic Plc - Geographic focus
  • Exhibit 85: Medtronic Plc - Segment focus
  • Exhibit 86: Medtronic Plc - Key offerings
  • Exhibit 87: MicroPort Scientific Corp. - Vendor overview
  • Exhibit 88: MicroPort Scientific Corp. - Business segments
  • Exhibit 89: MicroPort Scientific Corp. - Organizational developments
  • Exhibit 90: MicroPort Scientific Corp. - Geographic focus
  • Exhibit 91: MicroPort Scientific Corp. - Segment focus
  • Exhibit 92: MicroPort Scientific Corp. - Key offerings
  • Exhibit 93: Nihon Kohden Corp. - Vendor overview
  • Exhibit 94: Nihon Kohden Corp. - Business segments
  • Exhibit 95: Nihon Kohden Corp. - Organizational developments
  • Exhibit 96: Nihon Kohden Corp. - Geographic focus
  • Exhibit 97: Nihon Kohden Corp. - Segment focus
  • Exhibit 98: Nihon Kohden Corp. - Key offerings
  • Exhibit 99: Penumbra Inc. - Vendor overview
  • Exhibit 100: Penumbra Inc. - Business segments
  • Exhibit 101: Penumbra Inc. - Organizational developments
  • Exhibit 102: Penumbra Inc. - Geographic focus
  • Exhibit 103: Penumbra Inc. - Segment focus
  • Exhibit 104: Penumbra Inc. - Key offerings
  • Exhibit 105: Stryker Corp. - Vendor overview
  • Exhibit 106: Stryker Corp. - Business segments
  • Exhibit 107: Stryker Corp. - Organizational developments
  • Exhibit 108: Stryker Corp. - Geographic focus
  • Exhibit 109: Stryker Corp. - Segment focus
  • Exhibit 110: Stryker Corp. - Key offerings
  • Exhibit 111: Validation techniques employed for market sizing
  • Exhibit 112: Definition of market positioning of vendors
Back to Top